Case report: Spontaneous improvement and treatment considerations in leukoencephalopathy with calcifications and cysts

IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY
Shanice Beerepoot , Hilko Ardon , Anneke Niers , Marjo S. van der Knaap
{"title":"Case report: Spontaneous improvement and treatment considerations in leukoencephalopathy with calcifications and cysts","authors":"Shanice Beerepoot ,&nbsp;Hilko Ardon ,&nbsp;Anneke Niers ,&nbsp;Marjo S. van der Knaap","doi":"10.1016/j.clineuro.2024.108517","DOIUrl":null,"url":null,"abstract":"<div><p>We present the case of a patient with leukoencephalopathy with calcifications and cysts (LCC), who experienced progressive severe hemiparesis despite multiple neurosurgical interventions of a large contralateral cyst. Bevacizumab was proposed as an ultimate treatment option based on prior case reports. While awaiting reimbursement approval for bevacizumab, major improvement occurred in both clinical and radiological disease manifestations. The disease course of LCC is variable and unpredictable; neurosurgical treatment should be reserved for severe and progressive neurological deficits. Bevacizumab has been reported as a promising alternative treatment option. Importantly, in our case the observed clinical improvement would have been attributed to the effects of bevacizumab, if started when requested. Our case underscores the need for a natural history study for LCC and the necessity of validating treatment efficacy by systematic evaluation through appropriate clinical trials rather than relying on anecdotal evidence from published case reports.</p></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0303846724004049/pdfft?md5=85173cfdcc180efb2213767b3b3fca02&pid=1-s2.0-S0303846724004049-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neurology and Neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0303846724004049","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We present the case of a patient with leukoencephalopathy with calcifications and cysts (LCC), who experienced progressive severe hemiparesis despite multiple neurosurgical interventions of a large contralateral cyst. Bevacizumab was proposed as an ultimate treatment option based on prior case reports. While awaiting reimbursement approval for bevacizumab, major improvement occurred in both clinical and radiological disease manifestations. The disease course of LCC is variable and unpredictable; neurosurgical treatment should be reserved for severe and progressive neurological deficits. Bevacizumab has been reported as a promising alternative treatment option. Importantly, in our case the observed clinical improvement would have been attributed to the effects of bevacizumab, if started when requested. Our case underscores the need for a natural history study for LCC and the necessity of validating treatment efficacy by systematic evaluation through appropriate clinical trials rather than relying on anecdotal evidence from published case reports.

病例报告:伴有钙化和囊肿的白质脑病的自然好转和治疗注意事项
我们介绍了一例白质脑病伴钙化和囊肿(LCC)患者的病例,尽管对其对侧巨大囊肿进行了多次神经外科干预,但患者仍出现了进行性严重偏瘫。根据之前的病例报告,贝伐单抗被建议作为最终治疗方案。在等待贝伐珠单抗的报销批准期间,患者的临床和放射学疾病表现均有明显改善。LCC 的病程多变且不可预测;神经外科治疗应保留给严重和进行性神经功能缺损的患者。据报道,贝伐单抗是一种很有前景的替代治疗方案。重要的是,在我们的病例中,如果按要求开始使用贝伐单抗,观察到的临床改善本应归功于贝伐单抗的作用。我们的病例强调了对 LCC 进行自然病史研究的必要性,以及通过适当的临床试验进行系统评估来验证治疗效果的必要性,而不是依赖于已发表病例报告中的轶事证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Neurology and Neurosurgery
Clinical Neurology and Neurosurgery 医学-临床神经学
CiteScore
3.70
自引率
5.30%
发文量
358
审稿时长
46 days
期刊介绍: Clinical Neurology and Neurosurgery is devoted to publishing papers and reports on the clinical aspects of neurology and neurosurgery. It is an international forum for papers of high scientific standard that are of interest to Neurologists and Neurosurgeons world-wide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信